Cannabis-based drugs have been shown to relieve pain. This is the conclusion Franjo Grotenhermen and Kirsten Müller-Vahl in issue 29-30 of the German Medical Journal (Sections ▼ 2012, 109 (29-30): 495-501).
http://www.aerzteblatt.de/archiv/127598
Grotenhermen F, Müller-Vahl K: The Therapeutic Potential of Cannabis and Cannabinoids. Sections ▼ 2012, 109 (29-30): 495-501.
Cannabis
Credit: Wikipedia
The use of these drugs is in patients in whom the use of conventional drug treatment does not provide adequate relief of symptoms. These are: spasticity, pain, nausea and vomiting caused by chemotherapy or loss of appetite in HIV disease and neuropathic pain.
The clinical effects of various cannabis-based medicines is based primarily on the activation of endogenous cannabinoid receptors. The consumption for therapeutic use in adults will not lead to irreversible cognitive decline. However, the risk of such harm to young people (especially before puberty) increased significantly even at therapeutic use.
More than 100 controlled studies of cannabinoids tested since 1975 for various indications, the effect. The results have led many countries to the approval of cannabis-based medicines. In 2011, Germany was in the drug regulatory approval of a cannabis extract. The Joint Bundesauschuss in June 2012, a little added value attests to the indication and issue a temporary license until 2015. et
Contacts and sources:
German Aerzteblatt
The use of these drugs is in patients in whom the use of conventional drug treatment does not provide adequate relief of symptoms. These are: spasticity, pain, nausea and vomiting caused by chemotherapy or loss of appetite in HIV disease and neuropathic pain.
The clinical effects of various cannabis-based medicines is based primarily on the activation of endogenous cannabinoid receptors. The consumption for therapeutic use in adults will not lead to irreversible cognitive decline. However, the risk of such harm to young people (especially before puberty) increased significantly even at therapeutic use.
More than 100 controlled studies of cannabinoids tested since 1975 for various indications, the effect. The results have led many countries to the approval of cannabis-based medicines. In 2011, Germany was in the drug regulatory approval of a cannabis extract. The Joint Bundesauschuss in June 2012, a little added value attests to the indication and issue a temporary license until 2015. et
Contacts and sources:
German Aerzteblatt
http://www.aerzteblatt.de/archiv/127598
Grotenhermen F, Müller-Vahl K: The Therapeutic Potential of Cannabis and Cannabinoids. Sections ▼ 2012, 109 (29-30): 495-501.
No comments:
Post a Comment